Histopathological cutaneous alterations in systemic sclerosis: A clinicopathological study

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Van Praet, Jens T ^a   Smith, Vanessa ^a   Haspeslagh, Marc ^a,b   Degryse, Nele ^a   Elewaut, Dirk ^a   De Keyser, Filip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Stedelijk Ziekenhuis Roeselare   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

ADULT; ARTICLE; CELL INFILTRATION; CLINICAL EVALUATION; CONTROLLED STUDY; DERMATOLOGY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; DISEASE ASSOCIATION; EXOCYTOSIS; FEMALE; FOREARM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTIMA; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYOFIBROBLAST; PARAKERATOSIS; RODNAN SKIN SCORE; SKIN BIOPSY; SKIN DISEASE; SKIN EXAMINATION; SYSTEMIC SCLEROSIS; BIOPSY; IMMUNOHISTOCHEMISTRY; LIMITED SCLERODERMA; MIDDLE AGED; PATHOLOGY; SKIN;

ADULT; BIOPSY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; SKIN;

EID: 79953329144     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3267     Document Type: Article

References (22)

1. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006, 2:134-144. 10.1038/ncprheum0115, 16932673.
2. Akesson A, Fiori G, Krieg T, van den Hoogen FH, Seibold JR. Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 2003, 21:S5-S8.
3. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
4. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, Goulet JR, Rich E, Grodzicky T, Raymond Y, Senécal JL. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008, 58:3902-3912. 10.1002/art.24038, 19035499.
5. Smith V, Van Praet JT, Vandooren B, Van der Cruyssen B, Naeyaert JM, Decuman S, Elewaut D, De Keyser F. Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis 2010, 69:193-197. 10.1136/ard.2008.095463, 19103636.
6. Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst DE. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007, 110:1388-1396. 10.1182/blood-2007-02-072389, 1939909, 17452515.
7. Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum 2006, 54:3655-3660. 10.1002/art.22186, 17075814.
8. Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet JT, Deschepper E, Sulli A, Cutolo M. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study. Ann Rheum Dis 2010, 69:1092-1096. 10.1136/ard.2009.115568, 20439291.
9. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
10. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993, 20:1892-1896.
11. Montgomery H, O'Leary PA, Ragsdale WE. Dermatohistopathology of various types of scleroderma. AMA Arch Derm 1957, 75:78-87.
12. Prescott RJ, Freemont AJ, Jones CJ, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992, 166:255-263. 10.1002/path.1711660307, 1517881.
13. Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol 1998, 20:242-245. 10.1097/00000372-199806000-00003, 9650695.
14. Roumm AD, Whiteside TL, Medsger TA, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis: quantification, subtyping, and clinical correlations. Arthritis Rheum 1984, 27:645-653. 10.1002/art.1780270607, 6375682.
15. Fleming JN, Shulman HM, Nash RA, Johnson PY, Wight TN, Gown A, Schwartz SM. Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis. PLoS One 2009, 4:e6203. 10.1371/journal.pone.0006203, 2705674, 19587802.
16. Rongioletti F, Gambini C, Micalizzi C, Pastorino A, Rebora A. Mucin deposits in morphea and systemic scleroderma. Dermatology 1994, 189:157-158. 10.1159/000246821, 8075444.
17. Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am 2008, 34:199-220. ix, 10.1016/j.rdc.2007.11.001, 2706095, 18329541.
18. Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases: An Algorithmic Method Based on Pattern Analysis 1997, Baltimore: Williams & Wilkins, 2.
19. Baeten D, Demetter P, Cuvelier C, Van Den Bosch F, Kruithof E, Van Damme N, Verbruggen G, Mielants H, Veys EM, De Keyser F. Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 2000, 59:945-953. 10.1136/ard.59.12.945, 1753054, 11087697.
20. Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V. Systemic sclerosis: continuing progress in developing clinical measures of response. J Rheumatol 2007, 34:1194-1200.
21. Fitzpatrick TB, Wolff K, . Access Medicine Fitzpatrick's Dermatology in General Medicine 2008, New York: McGraw-Hill Medical, 7, Access Medicine.
22. Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, Leask A, Abraham D, Stratton R. Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford) 2008, 47:1754-1760. 10.1093/rheumatology/ken370, 18829709.